HK1223847A1 - 使用 分析進行癌症分期的方法 - Google Patents

使用 分析進行癌症分期的方法

Info

Publication number
HK1223847A1
HK1223847A1 HK16112287.9A HK16112287A HK1223847A1 HK 1223847 A1 HK1223847 A1 HK 1223847A1 HK 16112287 A HK16112287 A HK 16112287A HK 1223847 A1 HK1223847 A1 HK 1223847A1
Authority
HK
Hong Kong
Prior art keywords
spect
analysis
methods
staging cancer
staging
Prior art date
Application number
HK16112287.9A
Other languages
English (en)
Inventor
湯瑪斯．阿莫爾
Original Assignee
Molecular Insight Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Insight Pharm Inc filed Critical Molecular Insight Pharm Inc
Publication of HK1223847A1 publication Critical patent/HK1223847A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
HK16112287.9A 2013-10-18 2016-10-25 使用 分析進行癌症分期的方法 HK1223847A1 (zh)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201361892931P 2013-10-18 2013-10-18
US201461932212P 2014-01-27 2014-01-27
US201461932686P 2014-01-28 2014-01-28
US201461954183P 2014-03-17 2014-03-17
US201461955095P 2014-03-18 2014-03-18
US201462007747P 2014-06-04 2014-06-04
US201462064962P 2014-10-16 2014-10-16
PCT/US2014/061249 WO2015058151A2 (en) 2013-10-18 2014-10-17 Methods of using spect/ct analysis for staging cancer

Publications (1)

Publication Number Publication Date
HK1223847A1 true HK1223847A1 (zh) 2017-08-11

Family

ID=52826358

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16112287.9A HK1223847A1 (zh) 2013-10-18 2016-10-25 使用 分析進行癌症分期的方法

Country Status (8)

Country Link
US (1) US20150110716A1 (zh)
EP (1) EP3057620A4 (zh)
JP (1) JP2017500537A (zh)
CN (1) CN105792855A (zh)
AU (1) AU2014337055A1 (zh)
CA (1) CA2927103A1 (zh)
HK (1) HK1223847A1 (zh)
WO (1) WO2015058151A2 (zh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE47609E1 (en) 2007-12-28 2019-09-17 Exini Diagnostics Ab System for detecting bone cancer metastases
MY194484A (en) 2013-10-18 2022-11-30 Deutsches Krebsforsch Labeled Inhibitors of Prostate Specific Membrane Antigen (PSMA), Their use as Imaging Agents and Pharmaceutical Agents for the Treatment of Prostate Cancer
US11087459B2 (en) 2015-08-14 2021-08-10 Elucid Bioimaging Inc. Quantitative imaging for fractional flow reserve (FFR)
US11676359B2 (en) 2015-08-14 2023-06-13 Elucid Bioimaging Inc. Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology
US11094058B2 (en) * 2015-08-14 2021-08-17 Elucid Bioimaging Inc. Systems and method for computer-aided phenotyping (CAP) using radiologic images
US10176408B2 (en) * 2015-08-14 2019-01-08 Elucid Bioimaging Inc. Systems and methods for analyzing pathologies utilizing quantitative imaging
US11113812B2 (en) 2015-08-14 2021-09-07 Elucid Bioimaging Inc. Quantitative imaging for detecting vulnerable plaque
US11071501B2 (en) 2015-08-14 2021-07-27 Elucid Bioiwaging Inc. Quantitative imaging for determining time to adverse event (TTE)
US10755810B2 (en) 2015-08-14 2020-08-25 Elucid Bioimaging Inc. Methods and systems for representing, storing, and accessing computable medical imaging-derived quantities
FI127538B (en) * 2016-06-22 2018-08-31 Dextech Medical Ab MODIFIED Dextran Conjugates
WO2018081354A1 (en) 2016-10-27 2018-05-03 Progenics Pharmaceuticals, Inc. Network for medical image analysis, decision support system, and related graphical user interface (gui) applications
US10740880B2 (en) 2017-01-18 2020-08-11 Elucid Bioimaging Inc. Systems and methods for analyzing pathologies utilizing quantitative imaging
KR102027772B1 (ko) * 2017-02-07 2019-10-04 연세대학교 산학협력단 전립선암 진단에 관한 정보제공방법
AU2018308867A1 (en) * 2017-07-25 2020-01-16 Bayer Aktiengesellschaft Apparatus for radiopharmaceutical quantification of a body part
WO2019033098A2 (en) 2017-08-11 2019-02-14 Elucid Bioimaging Inc. QUANTITATIVE MEDICAL IMAGING REPORT
US10973486B2 (en) 2018-01-08 2021-04-13 Progenics Pharmaceuticals, Inc. Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
JP7448476B2 (ja) * 2018-01-08 2024-03-12 プロジェニクス ファーマシューティカルズ， インコーポレイテッド 高速ニューラルネットワークベースの画像セグメント化および放射性医薬品摂取判定のためのシステムおよび方法
US10664999B2 (en) 2018-02-15 2020-05-26 Adobe Inc. Saliency prediction for a mobile user interface
KR102184992B1 (ko) * 2018-10-19 2020-12-01 연세대학교 산학협력단 유방암 환자에서 수술 중 겨드랑이 림프절 전이 진단을 위한 디바이스
CN113272859A (zh) 2019-01-07 2021-08-17 西尼诊断公司 用于平台中立性全身图像分段的系统及方法
WO2020219619A1 (en) 2019-04-24 2020-10-29 Progenics Pharmaceuticals, Inc. Systems and methods for interactive adjustment of intensity windowing in nuclear medicine images
JP2022530039A (ja) 2019-04-24 2022-06-27 プロジェニクス ファーマシューティカルズ， インコーポレイテッド 転移を検出するための骨スキャン画像の自動化された対話型の分析のためのシステムおよび方法
JP2022543330A (ja) 2019-08-05 2022-10-12 エルシド バイオイメージング インコーポレイテッド 形態学的および血管周囲疾患の複合評価
US11900597B2 (en) 2019-09-27 2024-02-13 Progenics Pharmaceuticals, Inc. Systems and methods for artificial intelligence-based image analysis for cancer assessment
US11564621B2 (en) 2019-09-27 2023-01-31 Progenies Pharmacenticals, Inc. Systems and methods for artificial intelligence-based image analysis for cancer assessment
US11544407B1 (en) 2019-09-27 2023-01-03 Progenics Pharmaceuticals, Inc. Systems and methods for secure cloud-based medical image upload and processing
US11386988B2 (en) 2020-04-23 2022-07-12 Exini Diagnostics Ab Systems and methods for deep-learning-based segmentation of composite images
US11321844B2 (en) 2020-04-23 2022-05-03 Exini Diagnostics Ab Systems and methods for deep-learning-based segmentation of composite images
US11721428B2 (en) 2020-07-06 2023-08-08 Exini Diagnostics Ab Systems and methods for artificial intelligence-based image analysis for detection and characterization of lesions
US11887701B2 (en) 2021-06-10 2024-01-30 Elucid Bioimaging Inc. Non-invasive determination of likely response to anti-inflammatory therapies for cardiovascular disease
US11869186B2 (en) 2021-06-10 2024-01-09 Elucid Bioimaging Inc. Non-invasive determination of likely response to combination therapies for cardiovascular disease
US11887713B2 (en) 2021-06-10 2024-01-30 Elucid Bioimaging Inc. Non-invasive determination of likely response to anti-diabetic therapies for cardiovascular disease
US11887734B2 (en) 2021-06-10 2024-01-30 Elucid Bioimaging Inc. Systems and methods for clinical decision support for lipid-lowering therapies for cardiovascular disease
CN114067361B (zh) * 2021-11-16 2022-08-23 西北民族大学 一种spect成像的非病变热区切分方法与系统
CN117670883B (zh) * 2024-01-31 2024-05-07 中国医学科学院北京协和医院 一种鉴别高低级别膀胱癌的方法、设备和系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2514419A1 (en) * 2003-01-28 2004-08-12 Proscan Rx Pharma Inc. Prostate cancer diagnosis and treatment
WO2008059489A2 (en) * 2006-11-13 2008-05-22 Spectrum Dynamics Llc Radioimaging applications of and novel formulations of teboroxime
US8923952B2 (en) * 2006-12-11 2014-12-30 Mayo Foundation For Medical Education And Research System and method for quantitative molecular breast imaging
WO2010065902A2 (en) * 2008-12-05 2010-06-10 Molecular Insight Pharmaceuticals, Inc. Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma
EP2398504B1 (en) * 2009-02-17 2018-11-28 Cornell Research Foundation, Inc. Methods and kits for diagnosis of cancer and prediction of therapeutic value

Also Published As

Publication number Publication date
EP3057620A2 (en) 2016-08-24
JP2017500537A (ja) 2017-01-05
CA2927103A1 (en) 2015-04-23
US20150110716A1 (en) 2015-04-23
CN105792855A (zh) 2016-07-20
WO2015058151A2 (en) 2015-04-23
EP3057620A4 (en) 2017-05-24
WO2015058151A3 (en) 2015-06-11
AU2014337055A1 (en) 2016-05-12

Similar Documents

Publication Publication Date Title
HK1223847A1 (zh) 使用 分析進行癌症分期的方法
IL261259B (en) Compounds for positron emission tomography
IL245935A0 (en) Methods for RNA analysis
HK1214652A1 (zh) 用於檢測胰腺癌的方法和組合物
HK1220110A1 (zh) 治療肺癌的方法
HK1220155A1 (zh) 治療癌症的方法
SG11201510210XA (en) Methods for detecting prostate cancer
GB2525525B (en) Methods to enhance nuclear spectroscopy analysis
HK1213817A1 (zh) 治療癌症的方法
IL255046A0 (en) A biological sequence-based approach to binary analysis
HK1213634A1 (zh) 檢測癌症的方法
HK1220253A1 (zh) 診斷前列腺癌症的方法
EP2968542A4 (en) BIOMARKERS FOR RADIOTHERAPY
PL3071969T3 (pl) Sposób analizy
GB2520086B (en) Method of measuring isotope ratio
HK1219513A1 (zh) 治療癌症的方法
EP2952932A4 (en) POSITRONS CT DEVICE
SG11201506407VA (en) Kit for tumor imaging
EP2998730A4 (en) X-FLUORESCENCE ANALYZER
SG11201600911TA (en) Improved x-ray shield
HUE048625T2 (hu) Módszer rák kezelésére
GB201310476D0 (en) Scintillator
HK1218124A1 (zh) 使用抗 抗體的方法
GB201411005D0 (en) Collimator for radiotherapy apparatus
GB2513120B (en) Method of determining an isotope ratio